IMTX Institutional Ownership

Immatics N.V.

Latest close $9.77 as of Aug 5, 2026

Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred from changes in reported shares when available; it is not a list of individual trades or exact execution prices. Form 13F rows are quarter-end holding context only and do not establish an exact entry date.

Free access includes current parsed ownership filings, reported share changes, and ownership-percentage changes. Filing-specific significance scoring, disclosure-speed analysis, confirmation/divergence signals, and signal alerts require Investor or Pro. The overall institutional consensus preview remains public. Compare plans.

Cross-institution intelligence

Institutional Research

Each institution is compared with its own prior filing, then the latest institution-level directions are compared for breadth.

Latest filing May 15, 2026

Public consensus preview Accumulation leaning 64/100 institutional research score

1 tracked institution Latest filing May 15, 2026

1 accumulating across 1 comparable institution.

Accumulating1

Unchanged0

Reducing0

Exited0

The overall consensus is public. Detailed holder comparisons, breadth history, ownership charts, and filing-specific signal analysis remain part of Investor and Pro research.

Price context

52-week position is market context and does not change the institutional consensus score.

52-week low$3.30 52-week high$12.41

Latest close $9.77 71.0% through the range

Tracked institutions

Public holder names and filing freshness. Detailed institution-by-institution analysis is locked.

Latest observation Mar 31, 2026

T. Rowe Price Investment Management May 15, 2026 filed

Detailed institutional research

See what is driving the consensus.

Unlock holder-by-holder changes, ownership history, breadth by period, disclosure timing, and filing-specific signal analysis.

Create free account Compare Investor and Pro

A free account adds watchlists and reveals tracker research gauges. Investor or Pro unlocks the detailed research above.

Beneficial ownership filing history

Showing 3 of 5 parsed filing(s) · 2 older require more history access

Holder	Observed / filed	Reported change	Shares	Ownership	Observation	Filing	Latest
T. Rowe Price Investment Management CIK0001897612	Mar 31, 2026 observed May 15, 2026 filed · 45d Schedule 13G amendment	Reported accumulation	21.7M +3.3M	16.10% +1.00 pts	$9.84	$10.87	$9.77
T. Rowe Price Investment Management CIK0001897612	Jun 30, 2025 observed Aug 14, 2025 filed · 45d Schedule 13G amendment	Reported accumulation	18.3M +4.2M	15.10% +3.10 pts	$5.38	$5.90	$9.77
T. Rowe Price Investment Management CIK0001897612	Feb 28, 2025 observed Mar 7, 2025 filed · 7d Schedule 13G amendment	Reported accumulation	14.2M +3.5M	12.00% 0.00 pts	$4.38	$4.66	$9.77

Explore more institutional activity

Related research

Crawlable links to other securities with similar institutional consensus or recent multi-institution accumulation.

Similar research strength

COGT COGENT BIOSCIENCES INC 64/100 Accumulation leaning ELDN ELEDON PHARMACEUTICALS INC 64/100 Accumulation leaning PNTG PENNANT GROUP INC/THE 64/100 Accumulation leaning CVBF CVB FINANCIAL CORP 64/100 Accumulation leaning

Recent multi-institution accumulation

TVTX Travere Therapeutics, Inc. 2 accumulating Aug 6, 2026 PCVX VAXCYTE INC 2 accumulating Aug 6, 2026 VVX V2X INC 2 accumulating Aug 6, 2026 VSEC VSE CORP 3 accumulating Jul 31, 2026